Associated Papers
A case of ovarian Sertoli-Leydig cell tumor with high grade transformation harbouring DICER1 and TP53 mutations.
Němejcová K et al.
Virchows Archiv : an International Journal of Pathology, 2026
[Sertoli-leydig cell tumor of the ovary with rare DICER1 mutation locus: report of a case].
Xu C et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology, 2026
Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic Variants.
Trecourt A et al.
The American Journal of Surgical Pathology, 2026
Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG-TOP2 Study.
Tao K et al.
Cancer Science, 2026
Integrating evidence from protein domains to identify cancer driver mutations.
Ostroverkhova D et al.
Protein Science : a Publication of the Protein Society, 2026
STK11 mutations and deletions define a distinct subtype of cervical adenocarcinoma.
Robinson E et al.
Medrxiv : the Preprint Server for Health Sciences, 2026
Adult Patient with Primary Intracranial Sarcoma DICER1 Mutated: Therapy Leading to Prolonged Survival and Local Control.
Toma C et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, 2025
YAP1::MAML2 fusion, a newly identified genetic anomaly in a posterior fossa infant tumor, associated with the methylation class "embryonal tumor with multilayered rosettes, non-C19MC-altered" in the Heidelberg central nervous system tumor classifier and "embryonal tumor with multilayered rosettes-DICER" in the NIH classifier.
Godfraind C et al.
Acta Neuropathologica Communications, 2025
Diagnosing Thyroid Lesions Through A Morphology-Molecular Lens: Four Case-Based Lessons From 22nd International Congress of Cytology-Florence 2025.
Canberk S et al.
Diagnostic Cytopathology, 2025
A Distinctive DICER1-Related Wilms-Like Uterine Tumor: A Report of Eight Cases.
Turashvili G et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2025
Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid Malignancies.
Liu L et al.
Medcomm, 2025
Primary Intracranial Sarcoma, DICER1-Mutant, Diagnosed by DNA Methylation Profiling in an Adult Patient with Germline DICER1 Mutation: A Case Report.
Koleják R et al.
International Journal of Surgical Pathology, 2025
Somatic DICER1 pathogenic variants detected in a well-differentiated fetal lung adenocarcinoma diagnosed in a man with familial adenomatous polyposis.
Ahmed A et al.
Bjc Reports, 2025
Thyroblastoma in Pregnancy: Expanding the Cytomorphological Spectrum of a Novel DICER1 -Associated Entity, a Case Report and Literature Review.
Razack R et al.
Diagnostic Cytopathology, 2025
Genetic mechanisms of resistance to targeted KRAS inhibition.
Diaz BJ et al.
Biorxiv : the Preprint Server for Biology, 2025
Embryonal tumor with multilayered rosettes, DICER1-mutated, showing histologically unique neuronal differentiation after chemoradiotherapy.
Yamazaki A et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology, 2025
Ciliary Body Medulloepithelioma: Clinical and Pathologic Challenges with a Focus on Molecular Genetics.
August AH et al.
Seminars in Ophthalmology, 2025
DICER1 mutations in Bethesda category II, III, and IV thyroid nodules: A mutually exclusive relationship with BRAFV600E mutation.
Wang Y et al.
Cancer Cytopathology, 2025
A molecular and immunohistochemical study of 37 cases of ovarian Sertoli-Leydig cell tumor.
Němejcová K et al.
Virchows Archiv : an International Journal of Pathology, 2025
Somatic DICER1-Mutant Benign Thyroid Nodules in Adults: A Group of Follicular Nodular Disease With Continuous Growth.
Meng L et al.
The Journal of Clinical Endocrinology and Metabolism, 2025
DICER1 Mutational Spectrum in Intracranial CNS-Neoplasias-A Review and a Report from the CNS-InterREST GPOH Study Center.
Manea S et al.
Cancers, 2025
Pathological and clinical insights into DICER1 hotspot mutated Sertoli-Leydig cell tumors: a comparative analysis.
Lyu Z et al.
Diagnostic Pathology, 2025
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.
George SL et al.
Cancer Discovery, 2025
DICER1 associated cervical embryonal rhabdomyosarcoma in a 59-year-old woman.
Alfaraidi M et al.
Gynecologic Oncology Reports, 2025
Prognostic Significance of Germline DICER1 Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell Tumor.
Nelson AT et al.
Jco Precision Oncology, 2025
Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy.
Huang J et al.
Frontiers in Immunology, 2025
Diagnosis and treatment of thyroblastoma: a case report and review of literature.
Chen X et al.
Frontiers in Oncology, 2025
VarMeter2: An enhanced structure-based method for predicting pathogenic missense variants through Mahalanobis distance.
Ohno S et al.
Computational and Structural Biotechnology Journal, 2025
Anaplastic Sarcoma of the Kidney in a Child with DICER1 Syndrome: A Case Report.
Nagasaki-Maeoka E et al.
Surgical Case Reports, 2025
DICER1 Mutations Define the Landscape of Poorly Differentiated Thyroid Carcinoma in Children and Young Adults : Case Report and Literature Review.
Ver Berne J et al.
The American Journal of Surgical Pathology, 2024
DICER1-sarcomas of GYN tract: Expanding on an emerging entity.
Dashti NK et al.
Human Pathology, 2024
DICER1 Variants in Pediatric and Young Adult Thyroid Nodules.
Mastnikova K et al.
Thyroid : Official Journal of the American Thyroid Association, 2024
Liver-specific DICER1 syndrome model mice develop cystic liver tumors with defective primary cilia.
Oikawa K et al.
The Journal of Pathology, 2024
Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules.
Condello V et al.
The Journal of Clinical Endocrinology and Metabolism, 2024
Extraskeletal chondroma of the toe in a child with DICER1 tumor predisposition syndrome: support for a dominant negative mechanism.
Pelletier D et al.
Virchows Archiv : an International Journal of Pathology, 2024
Comprehensive evaluation of cytomorphologic, histologic, and molecular features of DICER1-altered thyroid lesions on FNA: A multipractice experience.
Lengyel K et al.
Cancer Cytopathology, 2024
Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases.
Jitpasutham T et al.
Cancer Cytopathology, 2024
Non-C19MC-altered embryonal tumor with multilayered rosettes in a young woman with DICER1 syndrome: case report and review of the literature.
Campos Mármol MC et al.
Pathologica, 2024
RAS-MAPK Pathway Mutations in Congenital Pulmonary Airway Malformations.
Windrich J et al.
American Journal of Respiratory and Critical Care Medicine, 2024
Sertoli-Leydig cell tumor with DICER1 mutation.
Jansen SN et al.
Gynecologic Oncology Reports, 2024
Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
Acosta AM et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2024
Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma.
Lin Y et al.
Frontiers in Oncology, 2024
DICER1-mutated rhabdomyosarcoma of the ovary with teratoid features.
Lethongsavarn V et al.
Genes, Chromosomes & Cancer, 2023
Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.
Wang Y et al.
Cancer Research, 2023
Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.
Vodicska B et al.
World Journal of Pediatrics : Wjp, 2023
Reclassification of two germline DICER1 splicing variants leads to DICER1 syndrome diagnosis.
Apellaniz-Ruiz M et al.
Familial Cancer, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.
Marques Da Costa ME et al.
Communications Biology, 2023
Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC.
Sakthikumar S et al.
Veterinary and Comparative Oncology, 2023
DICER1 platform domain missense variants inhibit miRNA biogenesis and lead to tumor susceptibility.
Pelletier D et al.
Nar Cancer, 2023